Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs

Biomaterials

Volumn 35, Issue 27, 2014, Pages 7940-7950

  Movellan, Julie ^a   Urbán, Patricia ^b,c   Moles, Ernest ^b,c   de la Fuente, Jesús M ^a,d   Sierra, Teresa ^a   Serrano, José Luis ^a   Fernàndez Busquets, Xavier ^b,c  

^a Instituto de Nanociencia y Materiales de Aragón   (Spain)

^b INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d FUNDACIÓN ARAID   (Spain)

Author keywords

Antimalarial targeted drug delivery; Dendrimers; Malaria; Nanomedicine; Plasmodium; Polymeric nanoparticles

Indexed keywords

DISEASES; DRUG DELIVERY; MALARIA CONTROL; MEDICAL NANOTECHNOLOGY;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL COMPOUNDS; DENDRITIC DERIVATIVES; MALARIA; PLASMODIUM; PLASMODIUM FALCIPARUM; POLYMERIC NANOPARTICLES; TARGETED DRUG DELIVERY;

DENDRIMERS;

CHLOROQUINE; DENDRIMER; NANOCARRIER; POLOXAMER; PRIMAQUINE; PROPIONIC ACID DERIVATIVE; ANTIMALARIAL AGENT; DRUG CARRIER; NANOPARTICLE; RHODAMINE; RHODAMINE B; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DEGRADATION; DRUG RELEASE; DRUG TARGETING; EXPERIMENTAL INFECTION; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOUSE; NANOENCAPSULATION; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BAGG ALBINO MOUSE; CELL DEATH; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; ERYTHROCYTE; GROWTH, DEVELOPMENT AND AGING; IC50; INTRAPERITONEAL DRUG ADMINISTRATION; MALARIA, FALCIPARUM; METABOLISM; PARASITOLOGY; SYNTHESIS; TIME; TOXICITY; ULTRASTRUCTURE;

ANIMALS; ANTIMALARIALS; CELL DEATH; CHLOROQUINE; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ERYTHROCYTES; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INHIBITORY CONCENTRATION 50; INJECTIONS, INTRAPERITONEAL; MALARIA, FALCIPARUM; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; NANOPARTICLES; PLASMODIUM FALCIPARUM; PRIMAQUINE; RHODAMINES; SURFACE-ACTIVE AGENTS; TIME FACTORS;

EID: 84903458354     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.05.061     Document Type: Article

References (70)

1. Griffith K.S., Lewis L.S., Mali S., Parise M.E. Treatment of malaria in the United States: a systematic review. JAMA 2007, 297:2264-2277.
2. World Health Organization World Malaria Report 2013 May 2014, Available from: URL. http://www.who.int/malaria/publications/world_malaria_report_2013/report/en/.
3. Gamo F.J., Sanz L.M., Vidal J., de Cozar C., Alvarez E., Lavandera J.L., et al. Thousands of chemical starting points for antimalarial lead identification. Nature 2010, 465:305-310.
4. Baird J.K. Effectiveness of antimalarial drugs. NEngl J Med 2005, 352:1565-1577.
5. White N.J. Assessment of the pharmacodynamic properties of antimalarial drugs invivo. Antimicrob Agents Chemother 1997, 41:1413-1422.
6. Mackinnon M.J., Marsh K. The selection landscape of malaria parasites. Science 2010, 328:866-871.
7. Read A.F., Huijben S. Evolutionary biology and the avoidance of antimicrobial resistance. Evol Appl 2009, 2:40-51.
8. Murambiwa P., Masola B., Govender T., Mukaratirwa S., Musabayane C.T. Anti-malarial drug formulations and novel delivery systems: a review. Acta Trop 2011, 118:71-79.
9. Duncan R., Gaspar R. Nanomedicine(s) under the microscope. Mol Pharmacol 2011, 8:2101-2141.
10. Owen S.C., Chan D.P.Y., Shoichet M.S. Polymeric micelle stability. Nano Today 2012, 7:53-65.
11. Kedar U., Phutane P., Shidhaye S., Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine: NBM 2010, 6:714-729.
12. Vrignaud S., Benoit J.P., Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials 2011, 32:8593-8604.
13. Kamaly N., Xiao Z., Valencia P.M., Radovic-Moreno A.F., Farokhzad O.C. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012, 41:2971-3010.
14. Urbán P., Valle-Delgado J.J., Mauro N., Marques J., Manfredi A., Rottmann M., et al. Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium. JControl Release 2014, 177:84-95.
15. Grayson S.M., Fréchet J.M.J. Convergent dendrons and dendrimers: from synthesis to applications. Chem Rev 2001, 101:3819-3868.
16. Carlmark A., Hawker C., Hult A., Malkoch M. New methodologies in the construction of dendritic materials. Chem Soc Rev 2009, 38:352-362.
17. Tomalia D.A. Dendrons/dendrimers: quantized, nano-element like building blocks for soft-soft and soft-hard nano-compound synthesis. Soft Matter 2010, 6:456-474.
18. Boas U., Heegaard P.M.H. Dendrimers in drug research. Chem Soc Rev 2004, 33:43-63.
19. Patri A.K., Kukowska-Latallo J.F., Baker J.R.J. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev 2005, 57:2203-2214.
20. Paleos C.M., Tsiourvas D., Sideratou Z. Molecular engineering of dendritic polymers and their application as drug and gene delivery systems. Mol Pharm 2007, 4:169-188.
21. Tekade R.K., Kumar P.V., Jain N.K. Dendrimers in oncology: an expanding horizon. Chem Rev 2008, 109:49-87.
22. Medina S.H., El-Sayed M.E.H. Dendrimers as carriers for delivery of chemotherapeutic agents. Chem Rev 2009, 109:3141-3157.
23. Mintzer M.A., Grinstaff M.W. Biomedical applications of dendrimers: a tutorial. Chem Soc Rev 2011, 40:173-190.
24. Tomalia D.A. Dendrimeric supramolecular and supramacromolecular assemblies. Supramolecular Polymers 2005, 187-256. CRC Press Taylor & Francis Group, Boca Raton, FL. A. Ciferri (Ed.).
25. Al-Jamal K.T., Ramaswamy C., Florence A.T. Supramolecular structures from dendrons and dendrimers. Adv Drug Deliv Rev 2005, 57:2238-2270.
26. Rosen B.M., Wilson C.J., Wilson D.A., Peterca M., Imam M.R., Percec V. Dendron-mediated self-assembly, disassembly, and self-organization of complex systems. Chem Rev 2009, 109:6275-6540.
27. Dong C.M., Liu G. Linear-dendritic biodegradable block copolymers: from synthesis to application in bionanotechnology. Polym Chem 2013, 4:46-52.
28. Percec V., Wilson D.A., Leowanawat P., Wilson C.J., Hughes A.D., Kaucher M.S., et al. Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures. Science 2010, 328:1009-1014.
29. Meyers S.R., Juhn F.S., Griset A.P., Luman N.R., Grinstaff M.W. Anionic amphiphilic dendrimers as antibacterial agents. JAm Chem Soc 2008, 130:14444-14445.
30. Wang Y., Grayson S.M. Approaches for the preparation of non-linear amphiphilic polymers and their applications to drug delivery. Adv Drug Deliv Rev 2012, 64:852-865.
31. Hillaireau H., Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009, 66:2873-2896.
32. Caminade A.M., Laurent R., Delavaux-Nicot B., Majoral J.P. "Janus" dendrimers: syntheses and properties. New J Chem 2012, 36:217-226.
33. Gitsov I., Wooley K.L., Fréchet J.M.J. Novel polyether copolymers consisting of linear and dendritic blocks. Angew Chem Int Ed Engl 1992, 31:1200-1202.
34. Amir R.J., Albertazzi L., Willis J., Khan A., Kang T., Hawker C.J. Multifunctional trackable dendritic scaffolds and delivery agents. Angew Chem Int Ed 2011, 50:3425-3429.
35. Wurm F., Frey H. Linear-dendritic block copolymers: the state of the art and exciting perspectives. Prog Polym Sci 2011, 36:1-52.
36. Carlmark A., Malmström E., Malkoch M. Dendritic architectures based on bis-MPA: functional polymeric scaffolds for application-driven research. Chem Soc Rev 2013, 42:5858-5879.
37. 1H NMR self-diffusion studies of dendritic aliphatic polyesters based on 2,2-bis(hydroxymethyl)propionic acid and 1,1,1-tris(hydroxyphenyl)ethane. JAm Chem Soc 1996, 118:6388-6395.
38. Gillies E.R., Fréchet J.M.J. Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. JAm Chem Soc 2002, 124:14137-14146.
39. Lee C.C., MacKay J.A., Fréchet J.M.J., Szoka F.C. Designing dendrimers for biological applications. Nat Biotechnol 2005, 23:1517-1526.
40. Lee C.C., Gillies E.R., Fox M.E., Guillaudeu S.J., Fréchet J.M.J., Dy E.E., et al. Asingle dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci U S A 2006, 103:16649-16654.
41. Goodwin A.P., Lam S.S., Fréchet J.M.J. Rapid, efficient synthesis of heterobifunctional biodegradable dendrimers. JAm Chem Soc 2007, 129:6994-6995.
42. van der Poll D.G., Kieler-Ferguson H.M., Floyd W.C., Guillaudeu S.J., Jerger K., Szoka F.C., et al. Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer. Bioconjug Chem 2010, 21:764-773.
43. Himo F., Lovell T., Hilgraf R., Rostovtsev V.V., Noodleman L., Sharpless K.B., et al. Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. JAm Chem Soc 2004, 127:210-216.
44. Urbán P., Estelrich J., Cortés A., Fernàndez-Busquets X. Ananovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells invitro. JControl Release 2011, 151:202-211.
45. Cranmer S.L., Magowan C., Liang J., Coppel R.L., Cooke B.M. An alternative to serum for cultivation of Plasmodium falciparum invitro. Trans R Soc Trop Med Hyg 1997, 91:363-365.
46. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. JParasitol 1979, 65:418-420.
47. Fidock D.A., Rosenthal P.J., Croft S.L., Brun R., Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov 2004, 3:509-520.
48. Movellan J. Dendritic derivatives as building blocks for biomedical applications, 2013 May 2014, PhD dissertation, Universidad de Zaragoza, Available from: URL: http://zaguan.unizar.es/record/10464.
49. Batrakova E.V., Kabanov A.V. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. JControl Release 2008, 130:98-106.
50. Wei Z., Hao J., Yuan S., Li Y., Juan W., Sha X., et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and invitro characterization. Int J Pharm 2009, 376:176-185.
51. Lee E.S., Oh Y.T., Youn Y.S., Nam M., Park B., Yun J., et al. Binary mixing of micelles using pluronics for a nano-sized drug delivery system. Colloids Surf B 2011, 82:190-195.
52. Dahmani F.Z., Yang H., Zhou J., Yao J., Zhang T., Zhang Q. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, invitro and invivo evaluation. Eur J Pharm Sci 2012, 47:179-189.
53. Yoncheva K., Calleja P., Agüeros M., Petrov P., Miladinova I., Tsvetanov C., et al. Stabilized micelles as delivery vehicles for paclitaxel. Int J Pharm 2012, 436:258-264.
54. ® block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 2002, 54:759-779.
55. ® block copolymers as novel polymer therapeutics for drug and gene delivery. JControl Release 2002, 82:189-212.
56. Pembouong G., Morellet N., Kral T., Hof M., Scherman D., Bureau M.F., et al. Acomprehensive study in triblock copolymer membrane interaction. JControl Release 2011, 151:57-64.
57. Yayon A., Ginsburg H. The transport of chloroquine across human erythrocyte membranes is mediated by a simple symmetric carrier. Biochim Biophys Acta 1982, 686:197-203.
58. Beutler E., Duparc S. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg 2007, 77:779-789.
59. Burgoine K.L., Bancone G., Nosten F. The reality of using primaquine. Malar J 2010, 9:376.
60. Chan T.K., Todd D., Tso S.C. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency. BMJ 1976, 2:1227-1229.
61. Goodyer I.D., Pouvelle B., Schneider T.G., Trelka D.P., Taraschi T.F. Characterization of macromolecular transport pathways in malaria-infected erythrocytes. Mol Biochem Parasitol 1997, 87:13-28.
62. Champion J.A., Katare Y.K., Mitragotri S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. JControl Release 2007, 121:3-9.
63. Gratton S.E.A., Ropp P., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 2008, 105:11613-11618.
64. Geng Y., Discher D.E. Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. JAm Chem Soc 2005, 127:12780-12781.
65. Agrawal P., Gupta U., Jain N.K. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials 2007, 28:3349-3359.
66. Bhadra D., Yadav A.K., Bhadra S., Jain N.K. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm 2005, 295:221-233.
67. Ciolkowski M., Petersen J.F., Ficker M., Janaszewska A., Christensen J.B., Klajnert B., et al. Surface modification of PAMAM dendrimer improves its biocompatibility. Nanomedicine 2012, 8:815-817.
68. Bhadra D., Bhadra S., Jain N.K. PEGylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether. JPharm Pharm Sci 2005, 8:467-482.
69. Bhadra D., Bhadra S., Jain N.K. PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate. Pharm Res 2006, 23:623-633.
70. Mahajan H.S., Shah S.K., Surana S.J. Nasal in situ gel containing hydroxy propyl β-cyclodextrin inclusion complex of artemether: development and invitro evaluation. JIncl Phenom Macrocycl Chem 2011, 70:49-58.